CCM
ARYE

Consonance Capital Management’s ARYA Sciences Acquisition Corp V Class A Ordinary Shares ARYE Stock Holding History

Consonance Capital Management’s Portfolio ARYE Stock Details ARYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-300,000
Closed -$2.91M – 9
2021
Q4 		$2.91M Hold
300,000
– – 1.9% 10
2021
Q3 		$2.96M Buy
+300,000
New +$2.98M 1.62% 7

Other funds holding ARYE

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Consonance Capital Management's ARYE Position: Q1 2022 in Review

Consonance Capital Management sold out of ARYA Sciences Acquisition Corp V Class A Ordinary Shares (ARYE) in Q1 2022, closing a stake of 300,000 shares — an estimated $2.91M sold.

Consonance Capital Management first reported a position in ARYE in Q3 2021 and held it in 2 quarters. The position peaked at $2.96M in Q3 2021. 53 funds tracked by Wall St. Rank hold ARYE as of Q1 2022.

  • Consonance Capital Management reported no remaining ARYA Sciences Acquisition Corp V Class A Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Consonance Capital Management sold 300,000 ARYA Sciences Acquisition Corp V Class A Ordinary Shares shares in Q1 2022, an estimated $2.91M.
  • Consonance Capital Management first reported a position in ARYA Sciences Acquisition Corp V Class A Ordinary Shares in Q3 2021 and held it in 2 quarters.
  • Consonance Capital Management's ARYA Sciences Acquisition Corp V Class A Ordinary Shares position peaked at $2.96M in Q3 2021.
  • 53 funds tracked by Wall St. Rank held ARYA Sciences Acquisition Corp V Class A Ordinary Shares as of Q1 2022.

Based on Consonance Capital Management's 13F filing for Q1 2022, filed 16 May 2022.